Health Research Alliance
jamacardiology_zelniker_2023_br_230001_1677502645.98956 (1).pdf (408.89 kB)
Download file

Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes A Secondary Analysis of the DECLARE-TIMI 58 Trial

Download (408.89 kB)
journal contribution
posted on 2023-03-02, 15:43 authored by Thomas Zelniker, Stephen D Wiviott, Ofri Mosenzon, Erica L Goodrich, Petr Jarolim, Avivit Cahn, Deepak Bhatt, Lawrence A. Leiter, Darren K. McGuire, John WildingJohn Wilding, averkov oleg, Andrzej Budaj, A. Parkhomenko, Kausik Ray, Ingrid Gause-Nilsson, A Langkilde, Martin Fredriksson, Itamar Raz, Marc S. Sabatine, David A Morrow

 In this study, NT-proBNP and hsTnT were associated with MACE in patients with T2D at high risk of atherosclerotic events, and in individuals with high levels of both biomarkers, dapagliflozin was associated with reduced MACE event rates. 


Grant ID


Usage metrics

    American Heart Association